- Home
- KTTA vs CISS Comparison
KTTA vs CISS Comparison
Compare KTTA & CISS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- CISS
- Stock Information
- Founded
- KTTA 2020
- CISS 2022
- Country
- KTTA United States
- CISS Greece
- Employees
- KTTA N/A
- CISS N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- CISS Marine Transportation
- Sector
- KTTA Health Care
- CISS Consumer Discretionary
- Exchange
- KTTA Nasdaq
- CISS Nasdaq
- Market Cap
- KTTA 2.8M
- CISS 2.8M
- IPO Year
- KTTA 2021
- CISS N/A
- Fundamental
- Price
- KTTA $0.89
- CISS $3.56
- Analyst Decision
- KTTA
- CISS
- Analyst Count
- KTTA 0
- CISS 0
- Target Price
- KTTA N/A
- CISS N/A
- AVG Volume (30 Days)
- KTTA 2.3M
- CISS 20.6K
- Earning Date
- KTTA 05-15-2025
- CISS 05-15-2025
- Dividend Yield
- KTTA N/A
- CISS N/A
- EPS Growth
- KTTA N/A
- CISS N/A
- EPS
- KTTA N/A
- CISS N/A
- Revenue
- KTTA N/A
- CISS $38,174,754.00
- Revenue This Year
- KTTA N/A
- CISS N/A
- Revenue Next Year
- KTTA N/A
- CISS N/A
- P/E Ratio
- KTTA N/A
- CISS N/A
- Revenue Growth
- KTTA N/A
- CISS N/A
- 52 Week Low
- KTTA $0.79
- CISS $2.85
- 52 Week High
- KTTA $7.50
- CISS $25.35
- Technical
- Relative Strength Index (RSI)
- KTTA 38.94
- CISS 43.43
- Support Level
- KTTA $0.87
- CISS $3.55
- Resistance Level
- KTTA $0.95
- CISS $3.83
- Average True Range (ATR)
- KTTA 0.07
- CISS 0.17
- MACD
- KTTA 0.01
- CISS -0.00
- Stochastic Oscillator
- KTTA 40.41
- CISS 1.59
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.